Fennec Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.75

-0.28 (-2.54%)

As of Jun 30, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +177.2% upside

Low Target $21.84

Average Target $29.80

High Target $37.23

Current Price $10.75

Current
$10.75

Target
$29.80

$21.84 $29.80 avg $37.23

Scenario Analysis

Bear Case

$21.84

103.2%

Low target

Base Case

$29.80

+177.2%

Avg target

Bull Case

$37.23

+246.3%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$10.59

1.5% from high

52-Week Low

$5.65

+90.3% from low

Target vs 52W High

$29.80

+181.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%